Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study
Article in Clinical Cancer Research (February 2024)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Article in Clinical Cancer Research (February 2024)
Article in Cancer Control (January 2024)
Article in Journal of Cancer (September 2023)